RLAY FY 2020 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$83M

Gross Profit

$79M95.7% margin

Operating Income

-$56M-67.5% margin

Net Income

-$52M-63.4% margin

EPS (Diluted)

$-2.56

Cash Flow

Operating Cash Flow

-$102M

Free Cash Flow

-$104M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$800M

Total Liabilities

$37M

Stockholders' Equity

$763M

Cash & Equivalents

$448M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83M	$0	—
Gross Profit	$79M	-$3M	+2880.5%
Operating Income	-$56M	-$84M	+33.6%
Net Income	-$52M	-$67M	+21.2%